Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC)

被引：0
|
作者：
Chen, L.
Shiah, H. S.
Chen, C. Y.
Lin, Y. J.
Lin, P. W.
Su, W. C.
Chang, J. Y.
机构：
[1] Natl Hlth Res Inst, Tainan, Taiwan
[2] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4587
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I/II study of the oral mTOR inhibitor RAD001 in patients with advanced Hematologic malignancies
    Yee, K
    O'Brien, S
    Wierda, W
    Thomas, D
    Kurzrock, R
    Fayad, L
    Hagemeister, F
    Goy, A
    Cortes, J
    Prestifilippo, J
    Szatrowski, T
    Kantarjian, H
    Giles, F
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S35 - S35
  • [2] A phase I/II study of the oral mTOR inhibitor RAD001 in patients with advanced hematologic malignancies.
    Yee, KWL
    Wierda, W
    O'Brien, S
    Thomas, D
    Kurzrock, R
    Fayad, LE
    Hagemeister, FB
    Cortes, J
    Prestifilippo, K
    Szatrowski, TP
    Kantarjian, HM
    Giles, FJ
    BLOOD, 2004, 104 (11) : 287B - 287B
  • [3] Phase I trial of patupilone (P) and RAD001 in patients (pts) with advanced solid tumors
    Stein, M. N.
    Knox, B.
    Wesolowsky, E.
    Levitt, M.
    Moss, R.
    Poplin, E.
    Mehnert, J.
    Gounder, M.
    Goodin, S.
    DiPaola, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer:: Results of a phase I study with pharmacokinetics
    Awada, Ahmad
    Cardoso, Fatima
    Fontaine, Christel
    Dirix, Luc
    De Greve, Jacques
    Sotiriou, Christos
    Steinseifer, Jutta
    Wouters, Carine
    Tanaka, Chiaki
    Zoellner, Ulrike
    Tang, Pui
    Piccart, Martine
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (01) : 84 - 91
  • [5] A Phase 1/2 Study of RAD001, a mTOR Inhibitor, In Patients with Myelofibrosis: Final Results
    Vannucchi, Alessandro M.
    Guglielmelli, Paola
    Lupo, Letizia
    Finazzi, Maria Chiara
    Tozzi, Lorenzo
    Biamonte, Flavia
    Masciulli, Arianna
    Susini, Maria Chiara
    Pancrazzi, Alessandro
    Finazzi, Guido
    Paratore, Simona
    Marchioli, Roberto
    Bosi, Alberto
    Barbui, Tiziano
    Rambaldi, Alessandro
    Barosi, Giovanni
    BLOOD, 2010, 116 (21) : 143 - 143
  • [6] A phase I study of temozolomide (TMZ) and RAD001 in patients (pts) with glioblastoma multiforme (GBM)
    Mason, W. P.
    MacNeil, M.
    Easaw, J.
    McIntosh, L.
    Lwin, Z.
    Chen, E.
    Eisenhauer, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] A phase I study with tumor molecular pharmacodynamic (MPD) evaluation of dose and schedule of the oral mTOR-inhibitor everolimus (RAD001) in patients (pts) with advanced solid tumors.
    Tabernero, J
    Rojo, F
    Burris, H
    Casado, E
    Macarulla, T
    Jones, S
    Dimitrijevic, S
    Hazell, K
    Shand, N
    Baselga, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 193S - 193S
  • [8] Phase I Clinical and Pharmacokinetic Study of RAD001 (Everolimus) Administered Daily to Japanese Patients with Advanced Solid Tumors
    Okamoto, Isamu
    Doi, Toshihiko
    Ohtsu, Atsushi
    Miyazaki, Masaki
    Tsuya, Asuka
    Kurei, Katsutoshi
    Kobayashi, Ken
    Nakagawa, Kazuhiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (01) : 17 - 23
  • [9] Dose-finding study of pegylated liposomal doxorubicin (PLD) and the mTOR inhibitor RAD001 (R) in patients (pts) with advanced solid tumors
    Sessa, C.
    Perotti, A.
    Delmonte, A.
    Del Conte, G.
    Gallerani, E.
    Fasolo, A.
    Zanaboni, F.
    Locatelli, A.
    Dall'O, E.
    Gianni, L.
    EJC SUPPLEMENTS, 2008, 6 (12): : 104 - 104
  • [10] Phase I and Pharmacokinetic (PK) Study of Everolimus (RAD001) in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL).
    Ogura, Michinori
    Uchida, Toshiki
    Maruyama, Dai
    Uike, Naokuni
    Choi, Ilseung
    Ishizawa, Kenichi
    Itoh, Kuniaki
    Ando, Kiyoshi
    Taniwaki, Masafumi
    Shimada, Naomi
    Kobayashi, Ken
    Tobinai, Kensei
    BLOOD, 2009, 114 (22) : 682 - 683
12345